Peripheral Neuropathy Trial, Recruiting NCT05950659 Sponsor: Johns Hopkins University Condition: Peripheral Neuropathy
Back to Peripheral Neuropathy

Peripheral Neuropathy Trial, Recruiting

NCT05950659
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with Type 1 or Type 2 diabetes
  • A doctor has confirmed you have nerve damage in your feet (neuropathy), tested using a simple touch test with a small filament
  • You have had a foot ulcer (sore) on the bottom of your foot or toe that fully healed within the last 12 months, putting you in a "high-risk" category
  • Any previous foot ulcers are completely healed, confirmed by two medical check-ups at least two weeks apart
  • You are able to walk at least 30 steps on your own — using a walker or cane is fine
  • You are 18 years of age or older
  • You have adequate blood flow to your feet, as measured by specific tests (confirm with trial site if unsure)
  • You are willing and able to use special pressure-relieving footwear as directed for the location of your healed ulcer
  • You are willing to wear special sensor insoles (Orpyx Sensory Insoles) while walking and at home during waking hours, for at least 5 hours per day
  • If you have had a partial foot amputation, it may still be compatible with the insoles, at the doctor's discretion

Who may not be able to join:

  • You currently have an open wound or active ulcer on your foot or leg for any reason
  • You have been diagnosed with dementia
  • You have a psychiatric illness or personal circumstances that might make it difficult to follow the study requirements
  • You have a serious heart, lung, or balance condition that stops you from walking at least 30 steps or standing for 5 minutes
  • You are currently in, or have recently (within the last 30 days) been in, another clinical study involving a device designed to prevent or offload diabetic foot ulcers
  • You are currently enrolled in any other remote foot monitoring program
  • You have a bone infection (osteomyelitis) or tissue death (gangrene) in your lower leg or foot
  • You have a serious foot joint condition called Charcot neuroarthropathy that has not been treated
  • You have a bunion that a doctor believes could cause a new ulcer to form
  • You have a severe foot positioning problem called extreme equinus (confirm with trial site)
  • Your foot size is larger than a Men's 14 or Women's 12 (US sizing)
  • You have an amputation above the ankle
  • You have a foot amputation that is not compatible with the insoles, in the doctor's opinion
  • You have foot deformities or amputations that would need surgery as the next step in your care, and the study footwear would not adequately help (reviewed by an outside panel)
  • Your doctor determines you are not suitable for the trial for another reason

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Caitlin Hicks, MD, John's Hopkins University

Phone: +1 (855) 996-7799

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
22 April 2026
Est. completion
1 May 2029

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Plantar ulcer recurrence

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov